Publications by authors named "Lea Saban-Roche"

Claim this Profile
O
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET).
Thomas Walter, Thierry Lecomte, Julien Hadoux, Patricia Niccoli, Léa Saban-Roche

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents: a randomized, multicenter controlled trial (ETICCO study).
Wafa Bouleftour, Thierry Muron, Aline Guillot, Fabien Tinquaut, Romain Rivoirard, Léa Saban-Roche

Support Care Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Withholding the Introduction of Anti-Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild-Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study).
Lola-Jade Palmieri, Laurent Mineur, David Tougeron, Benoît Rousseau, Victoire Granger, Léa Saban-Roche

Oncologist· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Posterior Reversible Encephalopathy Syndrome (PRES): About 4 cases].
Edouard Chanal, Wafa Bouleftour, Romain Rivoirard, Claire Bosaki, Fabien Forges, Léa Saban-Roche

Presse Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progression-free survival and time without treatment in patients with locally advanced pancreatic cancers.
Nicolas Williet, Thomas Di Bernardo, Chloé Vernet, Léa Saban Roche, Thierry Muron

Oncotarget· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Validation of a questionnaire assessing patients' adherence and skill level of management for oral capecitabine treatment].
Amandine Baudot, Mathieu Oriol, Fabien Tinquaut, Valentin Moine, Guillaume Moriceau, Léa Saban-Roche

Bull Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma.
Jean-Michel Prades, Benjamin Lallemant, Renaud Garrel, Emile Reyt, Christian Righini, Lea Saban-Roche

Acta Otolaryngol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis